This price target is based on 2 analysts offering 12 month price targets for lipocine in the last 3 months. Ladenburg thalm/sh sh raised lipocine from a neutral rating to a buy rating and set a $3.00 target price on the stock in a research []
5 Day Chart for NYSEHGV Insider trading, Chart, Vacation
Lpcn price target based on data provided by zacks investment research via quandl.com.
Lpcn stock forecast zacks. Calculation of earning per share of lipocine is based on official zacks consensus of 1 analysts regarding lipocine future annual earnings. Earnings growth (last year) +25.09%. This suggests a possible upside of 88.9% from the stock's current price.
Etfs holding lpcn | lipocine inc (new). Rating name price (usd) 7d forecast. (nasdaq:lpcn) to report earnings of ($0.05) per share for the current fiscal quarter, according to zacks investment research.
The average price target is $2.75, with a high forecast of $3.00 and a low forecast of $2.50. For the next fiscal year, analysts forecast that the firm will report earnings of $0.40 per share, with eps estimates ranging from ($0.15) to $1.23. On average, they anticipate lipocine's share price to reach $2.83 in the next twelve months.
Earnings growth (this year) +47.37%. From % to % filter reset / default. The average price target represents a 125.41% upside from the last price of $1.22.
Equities research analysts expect lipocine inc. Fundamental data provided by zacks and morningstar. Get the latest lipocine inc.
Common stock (lpcn) at nasdaq.com. Zero analysts have provided estimates for lipocines earnings. Find the latest dividend history for lipocine inc.
2 wall street analysts have issued ratings and price targets for lipocine in the last 12 months. Several other analysts also recently weighed in on lpcn. (lpcn) was a big mover last session, as the company saw its shares rise by roughly 12% on the day.
The net result is $100m. Annual profit (last year) $8.5m: Advertising opportunities on etf channel:
5.56.0.1 (opens in new window) 5.56.0.1 (opens in new window) Barchart is committed to ensuring digital accessibility for individuals with disabilities. $lpcn trt and the pipeline are worth $500m today.
Hc wainwright reiterated their buy rating on shares of lipocine (nasdaq:lpcn) in a research report report published on thursday, zacks.com reports. Annual revenue (last year) $130.7m: Eps forecast (this quarter) $0.03:
Is estimated to report earnings on 08/05/2021. Lpcn shares are down 13.7% at $1.18 during the market session on the last check wednesday. View analysts' price targets for lipocine or.
Their forecasts range from $2.50 to $3.00. The high price target for lpcn is $3.00 and the low price target for lpcn is $2.50. Cash markets overview corn indexes soybean indexes wheat indexes metal indexes energies indexes yield forecast indexes.
The upcoming earnings date is derived from an algorithm based on a company's historical. If we have a good partnership. Lpcn investment & stock information.
Mastercard (MA) Upgraded at Zacks Investment Research
Popular on 500px Lyngen aurora IV by andrewsteele
Resultado de imagen para imagenes de meryl streep Meryl
What the Cast of 'Gilmore Girls' Looked Like Then Versus
Best Forex Indicators System 29 JULY Review 250+ pips
Pin von Zack Viola auf firearms Star wars charaktere
depositphotos_14127801stockillustrationsketchweather
